N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl) tetrahydropyrazine-1 (2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain - Pomonis, J D; Harrison, J E; Mark, L; Bristol, D R; Valenzano, K J; Walker, K (J Pharmacol Exp Ther, 2003)